Cargando…
Specific targeting of IL-1β activity to CD8(+) T cells allows for safe use as a vaccine adjuvant
Annual administration and reformulation of influenza vaccines is required for protection against seasonal infections. However, the induction of strong and long-lasting T cells is critical to reach broad and potentially lifelong antiviral immunity. The NLRP3 inflammasome and its product interleukin-1...
Autores principales: | Van Den Eeckhout, Bram, Van Hoecke, Lien, Burg, Elianne, Van Lint, Sandra, Peelman, Frank, Kley, Niko, Uzé, Gilles, Saelens, Xavier, Tavernier, Jan, Gerlo, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378068/ https://www.ncbi.nlm.nih.gov/pubmed/32714571 http://dx.doi.org/10.1038/s41541-020-00211-5 |
Ejemplares similares
-
Selective IL-1 activity on CD8(+) T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
por: Van Den Eeckhout, Bram, et al.
Publicado: (2021) -
Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity
por: Van Den Eeckhout, Bram, et al.
Publicado: (2023) -
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE
por: Cauwels, Anje, et al.
Publicado: (2021) -
Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
por: Huyghe, Leander, et al.
Publicado: (2020) -
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state
por: Van Lint, Sandra, et al.
Publicado: (2023)